FDA Approves Alzheimer’s Drug For First Time In Years

FDA Approves Alzheimer’s Drug For First Time In Years

The Food and Drug administration approved a new drug for Alzheimer’s disease Monday, purportedly giving doctors a new but much-debated method of directly addressing the Alzheimer’s disease process instead of merely treating the symptoms of it. 

The drug, called aducanumab, was approved through the FDA’s accelerated approval program, which is reserved for drugs that “fill an unmet medical need based on a surrogate endpoint” but that do not definitively improve patient outcomes. As Stat News notes, this means that, while the drug has shown it can eliminate the toxic protein clumps experts believe contribute to dementia, the regulatory agency doesn’t know definitively if it actually helps improve cognition in the patients who receive it. 

“Alzheimer’s disease is a devastating illness that can have a profound impact on the lives of people diagnosed with the disease as well as their loved ones,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Currently available therapies only treat symptoms

Trending: Multiple Individuals Push Multiple Ballots through Multiple Tabulators Multiple Times in Georgia. This Is Illegal. Law Enforcement Does Nothing.

Continue reading

You Might Like

Daily Truth Report • DailyTruthReport.com
Thanks for sharing!
Send this to a friend